|
1
|
Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?
|
Leuk Res
|
2009
|
1.67
|
|
2
|
Clinical outcomes and breast cancer subtypes in patients with brain metastases.
|
Onkologie
|
2010
|
1.42
|
|
3
|
Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy.
|
Ann Hematol
|
2010
|
0.98
|
|
4
|
The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma.
|
Korean J Hematol
|
2010
|
0.89
|
|
5
|
Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma.
|
Korean J Intern Med
|
2009
|
0.88
|
|
6
|
Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.
|
J Neurooncol
|
2011
|
0.86
|
|
7
|
Influence of lactate dehydrogenase and cyclosporine A level on the incidence of acute graft-versus-host disease after allogeneic stem cell transplantation.
|
J Korean Med Sci
|
2009
|
0.84
|
|
8
|
Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura.
|
J Korean Med Sci
|
2008
|
0.83
|
|
9
|
Prognostic significance of the Bcl-2 negative germinal centre in patients with diffuse large B cell lymphoma treated with R-CHOP.
|
Leuk Lymphoma
|
2009
|
0.79
|
|
10
|
Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.
|
Cancer Chemother Pharmacol
|
2012
|
0.79
|
|
11
|
Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients.
|
Acta Haematol
|
2010
|
0.78
|
|
12
|
Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck.
|
Cancer Res Treat
|
2007
|
0.78
|
|
13
|
Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors.
|
Ann Hematol
|
2010
|
0.75
|
|
14
|
Nilotinib-induced bone marrow aplasia.
|
Eur J Haematol
|
2009
|
0.75
|
|
15
|
Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
|
Eur J Haematol
|
2009
|
0.75
|
|
16
|
Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia.
|
Acta Haematol
|
2011
|
0.75
|